πŸ‡ΊπŸ‡Έ FDA
Patent

US 10155811

APLNR modulators and uses thereof

granted A61KA61K38/00A61K38/08

Quick answer

US patent 10155811 (APLNR modulators and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Dec 18 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 13 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K38/22